137 related articles for article (PubMed ID: 21654841)
1. An intracytoplasmic IL-10 receptor variant permits rapid reduction in STAT3 activation.
Finsterbusch M; Khare V; Campregher C; Evstatiev R; Gasche C
Genes Immun; 2011 Oct; 12(7):575-81. PubMed ID: 21654841
[TBL] [Abstract][Full Text] [Related]
2. Signal transduction mechanism of the NZW type IL‑10R1 and the effect on B lymphocyte function.
Diao C; Qi Z; Du S; Cai X; Jiang Y
Mol Med Rep; 2014 Jul; 10(1):353-8. PubMed ID: 24737344
[TBL] [Abstract][Full Text] [Related]
3. IL10R1 loss-of-function alleles in rheumatoid arthritis and systemic lupus erythematosus.
Hermann J; Gruber S; Neufeld JB; Grundtner P; Graninger M; Graninger WB; Berghold A; Gasche C
Clin Exp Rheumatol; 2009; 27(4):603-8. PubMed ID: 19772791
[TBL] [Abstract][Full Text] [Related]
4. Differential signaling of cmvIL-10 through common variants of the IL-10 receptor 1.
Gruber SG; Gloria Luciani M; Grundtner P; Zdanov A; Gasche C
Eur J Immunol; 2008 Dec; 38(12):3365-75. PubMed ID: 19016528
[TBL] [Abstract][Full Text] [Related]
5. Homozygosity of the interleukin-10 receptor 1 G330R allele is associated with schizophrenia.
Schosser A; Aschauer HN; Wildenauer DB; Schwab SG; Albus M; Maier W; Schloegelhofer M; Leisch F; Hornik K; Murray SS; Gasche C
Am J Med Genet B Neuropsychiatr Genet; 2007 Apr; 144B(3):347-50. PubMed ID: 17066477
[TBL] [Abstract][Full Text] [Related]
6. The IL-10R1 S138G loss-of-function allele and ulcerative colitis.
Grundtner P; Gruber S; Murray SS; Vermeire S; Rutgeerts P; Decker T; Lakatos PL; Gasche C
Genes Immun; 2009 Jan; 10(1):84-92. PubMed ID: 18800073
[TBL] [Abstract][Full Text] [Related]
7. Novel variants of the IL-10 receptor 1 affect inhibition of monocyte TNF-alpha production.
Gasche C; Grundtner P; Zwirn P; Reinisch W; Shaw SH; Zdanov A; Sarma U; Williams LM; Foxwell BM; Gangl A
J Immunol; 2003 Jun; 170(11):5578-82. PubMed ID: 12759436
[TBL] [Abstract][Full Text] [Related]
8. Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute-phase protein expression.
Schaper F; Gendo C; Eck M; Schmitz J; Grimm C; Anhuf D; Kerr IM; Heinrich PC
Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):557-65. PubMed ID: 9794795
[TBL] [Abstract][Full Text] [Related]
9. Identification and molecular characterization of the interleukin-10 receptor 1 of the zebrafish (Danio rerio) and the goldfish (Carassius auratus L.).
Grayfer L; Belosevic M
Dev Comp Immunol; 2012 Feb; 36(2):408-17. PubMed ID: 21906622
[TBL] [Abstract][Full Text] [Related]
10. "Activated" STAT proteins: a paradoxical consequence of inhibited JAK-STAT signaling in cytomegalovirus-infected cells.
Trilling M; Le VT; Rashidi-Alavijeh J; Katschinski B; Scheller J; Rose-John S; Androsiac GE; Jonjic S; Poli V; Pfeffer K; Hengel H
J Immunol; 2014 Jan; 192(1):447-58. PubMed ID: 24319264
[TBL] [Abstract][Full Text] [Related]
11. JAK1 activates STAT3 activity in non-small-cell lung cancer cells and IL-6 neutralizing antibodies can suppress JAK1-STAT3 signaling.
Song L; Rawal B; Nemeth JA; Haura EB
Mol Cancer Ther; 2011 Mar; 10(3):481-94. PubMed ID: 21216930
[TBL] [Abstract][Full Text] [Related]
12. Acute lymphoblastic leukemia-associated JAK1 mutants activate the Janus kinase/STAT pathway via interleukin-9 receptor alpha homodimers.
Hornakova T; Staerk J; Royer Y; Flex E; Tartaglia M; Constantinescu SN; Knoops L; Renauld JC
J Biol Chem; 2009 Mar; 284(11):6773-81. PubMed ID: 19139102
[TBL] [Abstract][Full Text] [Related]
13. The activity of JAK-STAT pathways in rheumatoid arthritis: constitutive activation of STAT3 correlates with interleukin 6 levels.
Isomäki P; Junttila I; Vidqvist KL; Korpela M; Silvennoinen O
Rheumatology (Oxford); 2015 Jun; 54(6):1103-13. PubMed ID: 25406356
[TBL] [Abstract][Full Text] [Related]
14. Cytokine response is determined by duration of receptor and signal transducers and activators of transcription 3 (STAT3) activation.
Braun DA; Fribourg M; Sealfon SC
J Biol Chem; 2013 Feb; 288(5):2986-93. PubMed ID: 23166328
[TBL] [Abstract][Full Text] [Related]
15. Differential utilization of Janus kinase-signal transducer activator of transcription signaling pathways in the stimulation of human natural killer cells by IL-2, IL-12, and IFN-alpha.
Yu CR; Lin JX; Fink DW; Akira S; Bloom ET; Yamauchi A
J Immunol; 1996 Jul; 157(1):126-37. PubMed ID: 8683106
[TBL] [Abstract][Full Text] [Related]
16. Cross-talk between interleukin 1beta (IL-1beta) and IL-6 signalling pathways: IL-1beta selectively inhibits IL-6-activated signal transducer and activator of transcription factor 1 (STAT1) by a proteasome-dependent mechanism.
Shen X; Tian Z; Holtzman MJ; Gao B
Biochem J; 2000 Dec; 352 Pt 3(Pt 3):913-9. PubMed ID: 11104703
[TBL] [Abstract][Full Text] [Related]
17. Novel mechanism of inhibition of dendritic cells maturation by mesenchymal stem cells via interleukin-10 and the JAK1/STAT3 signaling pathway.
Liu WH; Liu JJ; Wu J; Zhang LL; Liu F; Yin L; Zhang MM; Yu B
PLoS One; 2013; 8(1):e55487. PubMed ID: 23383203
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic modification of SOCS-1 differentially regulates STAT3 activation in response to interleukin-6 receptor and epidermal growth factor receptor signaling through JAK and/or MEK in head and neck squamous cell carcinomas.
Lee TL; Yeh J; Van Waes C; Chen Z
Mol Cancer Ther; 2006 Jan; 5(1):8-19. PubMed ID: 16432158
[TBL] [Abstract][Full Text] [Related]
19. Evidence that IL-6-type cytokine signaling in cardiomyocytes is inhibited by oxidative stress: parthenolide targets JAK1 activation by generating ROS.
Kurdi M; Booz GW
J Cell Physiol; 2007 Aug; 212(2):424-31. PubMed ID: 17385713
[TBL] [Abstract][Full Text] [Related]
20. Src family kinase-independent signal transduction and gene induction by leukemia inhibitory factor.
Laszlo GS; Nathanson NM
J Biol Chem; 2003 Jul; 278(30):27750-7. PubMed ID: 12764151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
